Graphit rain poses health risk An assessment of potential health risks shows that graphite rain contains heavy metals and PAHs.
Updated immunisation recommendation for measles: early vaccination before travel A number of European countries are currently seeing outbreaks of measles. Before the start of the summer season, RIVM has therefore updated its immunisation recommendation for measles.
Affirmation of collaboration between Public Health England and RIVM On Thursday 11 April 2019, RIVM welcomed a delegation from Public Health England (PHE). Chief Executive Duncan Selbie of PHE headed the delegation.
Article in The Lancet Infectious Diseases on RIVM research into Maternal pertussis vaccination Scientific journal The Lancet Infectious Diseases has published an article on RIVM research conducted into pertussis vaccination for pregnant women.
Improving integrated care requires trust, a small-scale approach and a shared vision To improve integrated care for older people, professionals and organisations need to get to know each other, build trust and better understanding.
Join our HEVnet laboratory network now! Would you like to collaborate in an international laboratory network of hepatitis E virus (HEV) experts performing supranational studies and are you able to share HEV sequences in a shared reposito
Vaccination against meningococcal disease starts for teens aged 14 to 18 This spring, about 860,000 young people in the Netherlands will receive an invitation for a vaccination against meningococcal disease.
WHO Chemical Risk Assessment Workshop on new and emerging risks to human health from chemicals RIVM is hosting an international workshop on new and emerging risks from chemicals on 20 and 21 February 2019.
Kick off European Project VITAL: Vaccines and InfecTious diseases in the Ageing popuLation Recently, the EU-sponsored Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project was launched.